Genetically Predicted Immune Cells Mediate the Association between HLA-B and Cerebral Atherosclerosis

Authors

    Jiuchang Zhang, Zhongrui Yan Department of Neurology, Affiliated Hospital of Qingdao University, Qingdao 266100, Shandong, China Department of Neurology, Jining No. 1 People’s Hospital, Jining 270000, Shandong, China

DOI:

https://doi.org/10.18063/apm.v10i2.892

Keywords:

Immune cells, Mendelian randomization, HLA-B, Cerebral atherosclerosis

Abstract

Objective: Investigating the causal relationship between HLA Class l genes and cerebral atherosclerosis (CA) and identifying the role of immune cells as a potential mediator. Methods: The study conducted a Mendelian randomization (MR) study using an Inverse Variance Weighted (IVW) approach to investigate the causal role of HLA Class I genes in CA and the mediating effect of immune cells on this association. Results: MR Analysis determined that HLA-B (IVW: odds ratio (OR) = 1.4493, 95% confidence interval (CI) = 1.1296−1.8595, p = 0.0035) increased the risk of CA. In addition, 39 immune cell traits were associated with CA. Notably, the proportion of genetically predicted HLA-B mediated by Unsw Mem % lymphocyte was 13.1%. Conclusion: This study suggests a causal relationship between HLA-B and CA, possibly mediated by immune cells.

References

Zhang S, Zhang Q, Lu Y, et al., 2024, Roles of Integrin in Cardiovascular Diseases: From Basic Research to Clinical Implications. Int J Mol Sci, 25(7): 4096.

Chen L, Spagnolo-Allende A, Yang D, et al., 2024, Epidemiology, Pathophysiology, and Imaging of Atherosclerotic Intracranial Disease. Stroke, 55(2): 311–323.

Bae H, Lee J, Park J, et al., 2007, Risk Factors of Intracranial Cerebral Atherosclerosis Among Asymptomatics. Cerebrovasc Dis, 24(4): 355–360.

Napoli C, Palinski W, 2005, Neurodegenerative Diseases: Insights into Pathogenic Mechanisms from Atherosclerosis. Neurobiol Aging, 26(3): 293–302.

Witt K, 2023, Role of MHC Class I Pathways in Mycobacterium tuberculosis Antigen Presentation. Front Cell Infect Microbiol, 13: 1107884.

Wu X, Huang L, Huang Z, et al., 2022, The Lymphocyte-to-Monocyte Ratio Predicts Intracranial Atherosclerotic Stenosis Plaque Instability. Front Immunol, 13: 915126.

Louka A, Sagris D, Ntaios G, 2022, Immunity, Vascular Aging and Stroke. Curr Med Chem, 29(34): 5510–5521.

Burgess S, Davey G, Davies N, et al., 2023, Guidelines for Performing Mendelian Randomization Investigations: Update for Summer 2023. Wellcome Open Res, 4: 186.

Hänzelmann S, Castelo R, Guinney J, 2013, GSVA: Gene Set Variation Analysis for Microarray and RNA-seq Data. BMC Bioinformatics, 14: 7.

Orrù V, Steri M, Sidore C, et al., 2020, Complex Genetic Signatures in Immune Cells Underlie Autoimmunity and Inform Therapy. Nat Genet, 52(10): 1036–1045.

Ding W, Chen L, Xia J, et al., 2024, Causal Association Between Lipid-Lowering Drugs and Cancers: A Drug Target Mendelian Randomization Study. Medicine (Baltimore), 103(18): e38010.

Carter A, Sanderson E, Hammerton G, et al., 2021, Mendelian Randomisation for Mediation Analysis: Current Methods and Challenges for Implementation. Eur J Epidemiol, 36(5): 465–478.

Zhang C, Shi J, 2022, 7T MRI for Intracranial Vessel Wall Lesions and Its Associated Neurological Disorders: A Systematic Review. Brain Sci, 12(5): 528.

Zhang D, Jia N, Hu Z, et al., 2024, Bioinformatics Identification of Potential Biomarkers and Therapeutic Targets for Ischemic Stroke and Vascular Dementia. Exp Gerontol, 187: 112374.

Velican C, Velican D, 1982, Atherosclerotic Involvement of Human Intracranial Arteries with Special Reference to Intimal Necrosis. Atherosclerosis, 43(1): 59–69.

Kang D, Kim D, Kim J, et al., 2024, Emerging Concept of Intracranial Arterial Diseases: The Role of High Resolution Vessel Wall MRI. J Stroke, 26(1): 26–40.

Lu Y, Zhang X, Hu W, et al., 2021, The Identification of Candidate Biomarkers and Pathways in Atherosclerosis by Integrated Bioinformatics Analysis. Comput Math Methods Med, 2021: 6276480.

Sharma H, Mossman K, Austin R, 2024, Fatal Attractions That Trigger Inflammation and Drive Atherosclerotic Disease. Eur J Clin Invest, 54(5): e14169.

Fayos M, Arnaiz F, González V, et al., 2024, Progression of Subclinical Cardiovascular Disease in Patients with HIV. Rev Esp Quimioter, fayos29apr2024.

Wang C, Huang C, Yeh M, et al., 2024, Hepatitis C Virus Infection Associated with Coronary and Thoracic Aortic Atherosclerosis. Am J Med Sci, S0002-9629(24)01063-2.

Adiguzel Y, Mahroum N, Muller S, et al., 2023, Shared Pathogenicity Features and Sequences Between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity. Clin Rev Allergy Immunol, 65(2): 206–230.

Aranburu A, Piano E, Baban A, et al., 2017, Human B-cell Memory Is Shaped by Age- and Tissue-Specific T-Independent and GC-Dependent Events. Eur J Immunol, 47(2): 327–344.

Yuuki H, Itamiya T, Nagafuchi Y, et al., 2024, B Cell Receptor Repertoire Abnormalities in Autoimmune Disease. Front Immunol, 15: 1326823.

Hu F, Zhang W, Shi L, et al., 2018, Impaired CD27+IgD+ B Cells with Altered Gene Signature in Rheumatoid Arthritis. Front Immunol, 9: 626.

Sivri A, Hasçelik Z, 1995, IgM Deficiency in Systemic Lupus Erythematosus Patients. Arthritis Rheum, 38(11): 1713.

Meeuwsen J, Duijvenvoorde A, Gohar A, et al., 2017, High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease. J Am Heart Assoc, 6(9): e005747.

Downloads

Published

2025-06-28